NYSE · KVUE

Kenvue Inc.

Consumer Defensive · Household & Personal Products

$17.81▼ 0.34% ($0.06)at close

After hours$17.86▲ 0.29%7:51 PM ET

52-week

$14.02$20.13

Market cap

$34.20B

P/E

20.66

EPS (TTM)

$0.86

Next earnings

Nov 2, 2026

Valuation

Recommended · Earnings Power Value

Price used

$17.81

Zero-growth earnings power / share

$15.28

Zero-growth base case

This estimate is 14.21% below the price used.

USD · Financial years 2019–2025 · 7 years normalized

Method, dates & sources

The value of normalized operating earnings assuming no future growth. Conservative and optimistic figures vary the discount rate.

Price timestamp: Sep 18, 2026, 8:00 PM UTC
Financial statement period: Financial years 2019–2025 · 7 years normalized
Data refreshed: Sep 19, 2026, 12:24 PM UTC · provider

Why this method?

Positive FCFF exists, but it is still unstable and the operating history is too short to make a normalized FCFF DCF decision-useful. Use multiples and comparable transactions instead.

Is FCFF positive and has it been for 3+ consecutive years? 4 consecutive positive FCFF years are available.

Is FCFF stable (not swinging >30% year to year)? The largest recent FCFF swing is 397.6%.

Do you have 5+ years of positive FCFF history? Only 4 consecutive positive FCFF years are available, and the company only has 3 years of public or statement history.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -1.6%Revenue (TTM): 1.76%FCF (TTM): 29.63%P/FCF: 14th pct

What changed

The stock fell 1.6% over the last year. Revenue grew 1.76% over the trailing twelve months. Operating margin moved from 15.77% to 19.52%. Free cash flow grew 29.63% over the trailing twelve months.

What the market seems to be pricing

The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.

What would invalidate this read

Operating margin currently stands at 19.52%. A decisive move in revenue — currently up 1.76% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

Kenvue Inc. functions as a global leader in the consumer health sector.

CEOKirk L. Perry

SectorConsumer Defensive

IndustryHousehold & Personal Products

Employees21,890

IPO dateMay 4, 2023

https://www.kenvue.com

Market multiples

Forward P/E—

EV/EBITDA13.77

Enterprise value$40.42B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth3.02%

Gross margin (FY2025)58.13%▲0.2ppvs FY2024

Operating margin (FY2025)17.88%▲6.0ppvs FY2024

ROE15.58%▲1.2ppvs FY2025

Analyst consensus

RatingHold

Target price$19.50▲9.49%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 2, 2026

Q4 FY26 · EPS est $0.28 · Revenue est $3.86B

View

Dividends

$0.84/shareQuarterlyEx-div Sep 21, 2026 · in 2dAdequate

KVUE pays a dividend with a 4.69% declared yield, covered 1.1× by free cash flow.

Declared Yield

4.69%

Annual Div / Share

$0.84

CAGR

—

Payout Ratio

0.66%

Adequate

Dividend Growth Rate

Dividend Safety

8/10Adequate

Dividend History

Annualized dividend cycles per share

YearAnnual DivYoY

2026$0.84+1.2%

2025$0.83+1.9%

2024$0.81—

Income Projection

Invest

USD

Growth rate:

Reinvest dividends

Today

$47/yr

$4/mo

In 5 yrs

$47/yr

$4/mo

In 10 yrs

$47/yr

$4/mo

Today	In 5 yrs	In 10 yrs
$47/yr $4/mo	$47/yr $4/mo	$47/yr $4/mo

NYSE · KVUE

Kenvue Inc.

Consumer Defensive · Household & Personal Products

$17.81▼ 0.34% ($0.06)at close

After hours$17.86▲ 0.29%7:51 PM ET

52-week

$14.02$20.13

Market cap

$34.20B

P/E

20.66

EPS (TTM)

$0.86

Next earnings

Nov 2, 2026

Valuation

Recommended · Earnings Power Value

Price used

$17.81

Zero-growth earnings power / share

$15.28

Zero-growth base case

This estimate is 14.21% below the price used.

USD · Financial years 2019–2025 · 7 years normalized

Method, dates & sources

The value of normalized operating earnings assuming no future growth. Conservative and optimistic figures vary the discount rate.

Price timestamp: Sep 18, 2026, 8:00 PM UTC
Financial statement period: Financial years 2019–2025 · 7 years normalized
Data refreshed: Sep 19, 2026, 12:24 PM UTC · provider

Why this method?

Positive FCFF exists, but it is still unstable and the operating history is too short to make a normalized FCFF DCF decision-useful. Use multiples and comparable transactions instead.

Is FCFF positive and has it been for 3+ consecutive years? 4 consecutive positive FCFF years are available.

Is FCFF stable (not swinging >30% year to year)? The largest recent FCFF swing is 397.6%.

Do you have 5+ years of positive FCFF history? Only 4 consecutive positive FCFF years are available, and the company only has 3 years of public or statement history.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -1.6%Revenue (TTM): 1.76%FCF (TTM): 29.63%P/FCF: 14th pct

What changed

The stock fell 1.6% over the last year. Revenue grew 1.76% over the trailing twelve months. Operating margin moved from 15.77% to 19.52%. Free cash flow grew 29.63% over the trailing twelve months.

What the market seems to be pricing

What would invalidate this read

Operating margin currently stands at 19.52%. A decisive move in revenue — currently up 1.76% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

Kenvue Inc. functions as a global leader in the consumer health sector.

CEOKirk L. Perry

SectorConsumer Defensive

IndustryHousehold & Personal Products

Employees21,890

IPO dateMay 4, 2023

https://www.kenvue.com

Market multiples

Forward P/E—

EV/EBITDA13.77

Enterprise value$40.42B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth3.02%

Gross margin (FY2025)58.13%▲0.2ppvs FY2024

Operating margin (FY2025)17.88%▲6.0ppvs FY2024

ROE15.58%▲1.2ppvs FY2025

Analyst consensus

RatingHold

Target price$19.50▲9.49%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 2, 2026

Q4 FY26 · EPS est $0.28 · Revenue est $3.86B

View

Dividends

$0.84/shareQuarterlyEx-div Sep 21, 2026 · in 2dAdequate

KVUE pays a dividend with a 4.69% declared yield, covered 1.1× by free cash flow.

Declared Yield

4.69%

Annual Div / Share

$0.84

CAGR

—

Payout Ratio

0.66%

Adequate

Dividend Growth Rate

Dividend Safety

8/10Adequate

Dividend History

Annualized dividend cycles per share

YearAnnual DivYoY

2026$0.84+1.2%

2025$0.83+1.9%

2024$0.81—

Income Projection

Invest

USD

Growth rate:

Reinvest dividends

Today

$47/yr

$4/mo

In 5 yrs

$47/yr

$4/mo

In 10 yrs

$47/yr

$4/mo

Today	In 5 yrs	In 10 yrs
$47/yr $4/mo	$47/yr $4/mo	$47/yr $4/mo